Alexander Perniss

Dr. Alexander Perniss


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Science Advances
Verified
Journal Article
Open access
APAlexander Perniss
Alexander Perniss
BBBrett Boonen
Brett Boonen
STSarah Tonack
Sarah Tonack
MTMoritz Thiel
Moritz Thiel
KPKrupali Poharkar
Krupali Poharkar
WKWolfgang Kummer
Wolfgang Kummer
Host-derived succinate accumulates in the airways during bacterial infection. Here, we show that luminal succinate activates murine tracheal brush (tuft) cells through a signaling cascade involving the succinate receptor 1 (SUCNR1), phospholipase Cβ2, and the cation channel transient receptor potential channel subfamily M member 5 (TRPM5). Stimulated brush cells then trigger a long-range Ca 2+ wave spreading radially over the tracheal epithelium through a sequential signaling process. First, brush cells release acetylcholine, which excites nearby cells via muscarinic acetylcholine receptors. From there, the Ca 2+ wave propagates through gap junction signaling, reaching also distant ciliated and secretory cells. These effector cells translate activation into enhanced ciliary activity and Cl − secretion, which are synergistic in boosting mucociliary clearance, the major innate defense mechanism of the airways. Our data establish tracheal brush cells as a central hub in triggering a global epithelial defense program in response to a danger-associated metabolite.

2 February 2024 in Science Immunology
Verified
Journal Article
Closed access
SUSaltanat Ualiyeva
Saltanat Ualiyeva
ELEvan Lemire
Evan Lemire
CWCaitlin Wong
Caitlin Wong
APAlexander Perniss
Alexander Perniss
ABAmelia A. Boyd
Amelia A. Boyd
AHAdam L. Haber
Adam L. Haber
The olfactory neuroepithelium serves as a sensory organ for odors and forms part of the nasal mucosal barrier. Olfactory sensory neurons are surrounded and supported by epithelial cells. Among them, microvillous cells (MVCs) are strategically positioned at the apical surface, but their specific functions are enigmatic, and their relationship to the other specialized epithelial cells is unclear. Here, we establish that the family of MVCs comprises tuft cells and ionocytes in both mice and humans. Integrating analysis of the respiratory and olfactory epithelia, we define the distinct receptor expression of TRPM5 + tuft-MVCs compared with Gɑ-gustducin high respiratory tuft cells and characterize a previously undescribed population of glandular DCLK1 + tuft cells. To establish how allergen sensing by tuft-MVCs might direct olfactory mucosal responses, we used an integrated single-cell transcriptional and protein analysis. Inhalation of Alternaria induced mucosal epithelial effector molecules including Chil4 and a distinct pathway leading to proliferation of the quiescent olfactory horizontal basal stem cell (HBC) pool, both triggered in the absence of olfactory apoptosis. Alternaria- and ATP-elicited HBC proliferation was dependent on TRPM5 + tuft-MVCs, identifying these specialized epithelial cells as regulators of olfactory stem cell responses. Together, our data provide high-resolution characterization of nasal tuft cell heterogeneity and identify a function of TRPM5 + tuft-MVCs in directing the olfactory mucosal response to allergens.

2 January 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
TDTahereh Derakhshan
Tahereh Derakhshan
EHEleanor Hollers
Eleanor Hollers
APAlexander Perniss
Alexander Perniss
TRTessa Ryan
Tessa Ryan
AMAlanna McGill
Alanna McGill
DDDaniel F. Dwyer
Daniel F. Dwyer
Mast cells (MCs) expressing a distinctive protease phenotype (MC T s) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MC T s are phenotypically distinct from subepithelial MCs (MC TC s), signals driving human MC T differentiation and this subset’s contribution to inflammation remain unexplored. Here, we have identified TGF-β as a key driver of the MC T transcriptome in nasal polyps. We found that short-term TGF-β signaling alters MC cell surface receptor expression and partially recapitulated the in vivo MC T transcriptome, while TGF-β signaling during MC differentiation upregulated a larger number of MC T -associated transcripts. TGF-β inhibited the hallmark MC TC proteases chymase and cathepsin G at both the transcript and protein level, allowing selective in vitro differentiation of MC T s for functional study. We identified discrete differences in effector phenotype between in vitro–derived MC T s and MC TC s, with MC T s exhibiting enhanced proinflammatory lipid mediator generation and a distinct cytokine, chemokine, and growth factor production profile in response to both innate and adaptive stimuli, recapitulating functional features of their tissue-associated counterpart MC subsets. Thus, our findings support a role for TGF-β in promoting human MC T differentiation and identified a discrete contribution of this cell type to T2 inflammation.

Verified
Journal Article
Open access
PDF file
ATAnnalena Traum
Annalena Traum
SJStefanie Jehle
Stefanie Jehle
YWYannick Waxmann
Yannick Waxmann
ALAnne-Sophie Litmeyer
Anne-Sophie Litmeyer
HBHeike Berghöfer
Heike Berghöfer
BBBehnaz Bayat
Behnaz Bayat
CD177 is a glycosyl phosphatidyl inositol (GPI)-linked, neutrophil-specific glycoprotein that in 3–5% of normal individuals is absent from all neutrophils. The molecular mechanism behind the absence of CD177 has not been unravelled completely. Here, we analyse the impact of the recently described CD177 c.1291G>A variant on CD177 expression. Recombinant CD177 c.1291G>A was expressed in HEK293F cells and its expression on the cell surface, inside the cell, and in the culture supernatant was investigated. The CD177 c.1291G>A protein was characterised serologically and its interaction with proteinase 3 (PR3) was demonstrated by confocal laser scanning microscopy. Our experiments show that CD177 c.1291G>A does not interfere with CD177 protein biosynthesis but affects the membrane expression of CD177, leading to very low copy numbers of the protein on the cellular surface. The mutation does not interfere with the ability of the protein to bind PR3 or human polyclonal antibodies against wild-type CD177. Carriers of the c.1291G>A allele are supposed to be phenotyped as CD177-negative, but the protein is present in soluble form. The presence of CD177 c.1291A leads to the production of an unstable CD177 protein and an apparent “CD177-null” phenotype.

1 July 2024 in Trends in Parasitology
Verified
Journal Article
Closed access
APAlexander Perniss
Alexander Perniss
LBLora G. Bankova
Lora G. Bankova

1 September 2025 in Cell and tissue research
Verified
Journal Article
Open access
PDF file
WMWafaa Mahmoud
Wafaa Mahmoud
APAlexander Perniss
Alexander Perniss
KPKrupali Poharkar
Krupali Poharkar
MKMaryam Keshavarz
Maryam Keshavarz
UGUlrich Gärtner
Ulrich Gärtner
WKWolfgang Kummer
Wolfgang Kummer
Previous studies identified a rare cell type in the mouse tracheal epithelium with immunoreactivity to the microvillus protein villin (Vil1), which persisted in mice lacking tuft cells due to deletion of the transcription factor Pou2f3. This study aimed to clarify the identity of this ill-defined cell type. Ultrastructurally, all cells with tightly packed microvilli observed in the tracheal epithelium of Pou2f3 −/−-mice contained basally located dense core vesicles, a characteristic feature of neuroendocrine cells (NEC). Accordingly, immunofluorescence double-labeling utilizing NEC markers revealed villin-labeling in two thirds of NEC in the trachea, a reporter mouse strain showed Cre recombinase activity driven by the Vil1 promoter in a subpopulation of tracheal NEC, and analysis of single cell RNA sequencing data revealed Vil1-mRNA expression by tracheal NEC. Notably, only a minimal fraction (≈1%) of bronchopulmonary NEC (solitary and clustered in neuroepithelial bodies) displayed villin-immunoreactivity, despite nearly half of them having a history of Vil1 promoter activity. Microvilli of tuft cells differed ultrastructurally from those of NEC, and the majority of tuft cells were immunoreactive to advillin (Avil), showed Avil promoter activity as indicated by a reporter mouse strain, and expressed Avil-mRNA in the sequencing data set. This study uncovers villin-expressing cells in the lower airways as a cell population hidden among NEC. Advillin, not villin, is identified as a marker for airway tuft cells. This should be considered in interpreting findings based on the use of villin as a marker or Cre-driver when investigating rare cells in the murine airways. Graphical Abstract In mice, neuroendocrine cells express villin and persist in Pou2f3-deficient mice. Tuft cells, on the other hand, express advillin and are absent in Pou2f3-deficient mice.